12:00 AM
 | 
Feb 25, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Sequenta sales and marketing update

Sequenta launched ClonoSIGHT in the U.S. to detect residual disease in patients with acute lymphoblastic leukemia (ALL),...

Read the full 73 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >